General Information of the Compound
Compound ID
CP0579965
Compound Name
US10155731, Example 270
    Show/Hide
Synonyms
1399849-02-5
BDBM212579
C2M78A9V6Z
CHEMBL4110551
CS-0567609
Carbamic acid, N-(3-(3-((1R)-1-(cyclopropyl((2R)-2-morpholinylcarbonyl)amino)ethyl)-6-methyl-1H-pyrazolo(3,4-b)pyridin-1-yl)propyl)-, methyl ester
GLXC-26423
GTPL12196
HY-151111
Methyl (3-(3-((R)-1-((R)-N-cyclopropylmorpholine-2-carboxamido)ethyl)-6-methyl-1H-pyrazolo[3,4-b]pyridin-1-yl)propyl)carbamate
SCHEMBL16471589
SPH-3127
SPH3127
US9278944, 270
compound 18 [PMID: 35939295]
    Show/Hide
Structure
Formula
C22H32N6O4
Molecular Weight
444.536
Canonical SMILES
COC(=O)NCCCn1nc([C@@H](C)N(C2CC2)C(=O)[C@H]2CNCCO2)c2ccc(C)nc12
    Show/Hide
InChI
InChI=1S/C22H32N6O4/c1-14-5-8-17-19(26-27(20(17)25-14)11-4-9-24-22(30)31-3)15(2)28(16-6-7-16)21(29)18-13-23-10-12-32-18/h5,8,15-16,18,23H,4,6-7,9-13H2,1-3H3,(H,24,30)/t15-,18-/m1/s1
    Show/Hide
InChIKey
GRTDDIZIUSADLD-CRAIPNDOSA-N
CAS
1399849-02-5
Physicochemical Property
logP
1.52622
Rotatable Bonds
8
Heavy Atom Count
32
Polar Areas
110.61
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 117877477
ChEMBL ID
CHEMBL4110551
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00853, Renin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 0.4 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.4 nM
Clinical Information about the Compound
Drug 1 ( SPH3127 )
Drug Name SPH3127
Company Shanghai Pharma Biotherapeutics San Diego, CA
Indication
Ulcerative colitis
Phase 2
Target(s)
Angiotensinogenase renin (REN)
Inhibitor